Patents by Inventor Peter Bridge

Peter Bridge has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20050115567
    Abstract: A respirator assembly e.g. for NBC protection is formed from two separate sub-assemblies. The first sub-assembly comprises a flexible hood (or other suitable headgear), a rigid mounting ring and a peripheral face seal. The second sub-assembly comprise a face plate with lens, oronasal mask and inlet and outlet valves, and is demountably attachable to the ring. The first sub-assembly can be worn on its own with the user breathing ambient air through the front end, the second sub-assembly being added if and when a hazard is encountered. The positioning of the face seal in the first sub-assembly means that a comfortable and reliable fit can be ensured when the sub-assembly is donned prior to a mission, but the user is relieved of the physiological burden of wearing the complete respirator unless and until protection is required.
    Type: Application
    Filed: April 25, 2003
    Publication date: June 2, 2005
    Inventors: Peter Bridges, Adrian Huggins, Barry Short
  • Patent number: 5248667
    Abstract: Peptides previously disclosed as useful for preventing HIV from binding to cell binding sites have now been shown to have thymoleptic qualities and to be useful for tretment of psoriasis in patients who lack antibodies against HIV.
    Type: Grant
    Filed: July 18, 1991
    Date of Patent: September 28, 1993
    Assignee: The United States of America as represented by the Secretary of the Department of Health & Human Services
    Inventors: Peter Bridge, Frederick K. Goodwin
  • Patent number: 5063206
    Abstract: The present invention relates to methods of treating mental disorders and memory deficits not caused by HIV infection. The methods involve administration of a thymoleptic effective amount of defined linear peptides to patients. The peptides can be administered for example, as a powder or a solution obtained by dissolving a powder in a pharmaceutically acceptable solvent.
    Type: Grant
    Filed: May 16, 1989
    Date of Patent: November 5, 1991
    Assignee: The United States of Americas as represented by the Department of Health and Human Services
    Inventors: Peter Bridge, Frederick K. Goodwin